Fan, D.; Yang, H.; Mao, W.; Rask, P.J.; Pang, L.; Xu, C.; Vankayalapat, H.; Ahmed, A.A.; Bast, R.C., Jr.; Lu, Z.
A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin. Cancers 2021, 13, 446.
https://doi.org/10.3390/cancers13030446
AMA Style
Fan D, Yang H, Mao W, Rask PJ, Pang L, Xu C, Vankayalapat H, Ahmed AA, Bast RC Jr., Lu Z.
A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin. Cancers. 2021; 13(3):446.
https://doi.org/10.3390/cancers13030446
Chicago/Turabian Style
Fan, Dengxuan, Hailing Yang, Weiqun Mao, Philip J. Rask, Lan Pang, Congjian Xu, Hariprasad Vankayalapat, Ahmed A. Ahmed, Robert C. Bast, Jr., and Zhen Lu.
2021. "A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin" Cancers 13, no. 3: 446.
https://doi.org/10.3390/cancers13030446
APA Style
Fan, D., Yang, H., Mao, W., Rask, P. J., Pang, L., Xu, C., Vankayalapat, H., Ahmed, A. A., Bast, R. C., Jr., & Lu, Z.
(2021). A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin. Cancers, 13(3), 446.
https://doi.org/10.3390/cancers13030446